O. Cinkilic et al., Selective agonism of group IP2X receptors by dinucleotides dependent on a single adenine moiety, J PHARM EXP, 299(1), 2001, pp. 131-136
Citations number
32
Categorie Soggetti
Pharmacology & Toxicology
Journal title
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
We have investigated the activity of naturally occurring highperformance li
quid chromatography-purified diadenosine polyphosphates (Ap(n)A, n = 5-6),
adenosine polyphospho guanosines (AP(n)G, n = 5-6), and diguanosine polypho
sphates (Gp(n)G, n = 5-6) under voltage-clamp conditions at recombinant rat
P2X(1-4) purinoceptor subtypes expressed in Xenopus laevis oocytes. At rP2
X(1) and rP2X(3) receptors, Ap(n)As and AP(n)Gs evoked concentration-depend
ent inward currents. Gp(n)Gs were not active at these receptors. At rP2X(2)
and rP2X(4) receptors, dinucleotides did not show significant activity. Fo
r the rP2X(1) receptor, AP(n)As and AP(n)Gs were partial agonists; for the
P2X(3) receptor, only AP(5)G was full agonist, whereas the other tested sub
stances were partial agonists. The rank order of potency at rP2X(1) was ATP
greater than or equal to Ap(6)A greater than or equal to Ap(5)A greater th
an or equal to Ap(6)G greater than or equal to Ap(5)G, and rank order of ef
ficacy was ATP greater than or equal to Ap(5)A greater than or equal to Ap(
6)A > Ap(5)G > Ap(6)G, whereas at rP2X(3) the rank order of potency was ATP
> Ap(5)G greater than or equal to Ap(5)A greater than or equal to Ap(6)A g
reater than or equal to Ap(6)G and the rank order of efficacy was ATP appro
ximate to Ap(5)G greater than or equal to Ap(5)A approximate to Ap(6)A grea
ter than or equal to Ap(6)G. For rP2X(1) and rP2X(3) it is evident that rec
eptor agonism depended on the presence of at least one adenine moiety in th
e dinucleotide, while the presence of a guanine moiety had a significant im
pact and decreased agonist efficacy. The data suggest that naturally occurr
ing Ap,As and Ap,Gs may play an important physiological role in different h
uman tissues and systems by activating group I P2X receptors.